Immune Pharmaceuticals - Articles and news items

Immune Pharmaceuticals initiates Phase II trials of bertilimumab in ulcerative colitis and bullous pemphigoid

Industry news / 26 June 2015 / Victoria White

Immune Pharmaceuticals has initiated a Phase II trial of bertilimumab in ulcerative colitis and will initiate a Phase II bullous pemphigoid trial in July…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+